Sign inJoin waitlistJoin the waitlist

Christine McMahon

Assistant Professor · University of Colorado School of Medicine

Credentials: · · · · · · ·

History

University of Colorado School of Medicine
Present

Hospital of the University of Pennsylvania
2015–2018
Hospital of the University of Pennsylvania
2012–2015
Duke University School of Medicine
2008–2012
Duke University
2003–2007

Research

Clonal Selection with RAS Pathway Activation Mediates Secondary Clinical Resistance to Selective FLT3 Inhibition in Acute Myeloid Leukemia
Cancer Discovery · 2019 · First of 21 authors · 371 citations
Menin Inhibition With Revumenib for KMT2A-Rearranged Relapsed or Refractory Acute Leukemia (AUGMENT-101)
Journal of Clinical Oncology · 2025 · 213 citations
Stem and progenitor cells in myelodysplastic syndromes show aberrant stage-specific expansion and harbor genetic and epigenetic alterations
Blood · 2012 · 194 citations

Daniel Pollyea
23 papers
Maria Amaya
20 papers
Jon Gutman
15 papers
Marc Schwartz
14 papers
Andrew Kent
11 papers · 7 as a fellow
Clayton Smith
11 papers
Alexander Perl
7 papers
Jeffrey Schowinsky
7 papers
Yazan Madanat
7 papers
Andrew Brunner
6 papers
ES
Eytan Stein
6 papers
Joshua Zeidner
6 papers

Clinical trials

Cladribine Venetoclax in Monocytic AML
Principal investigator · Active not recruiting · Phase 2
University of Colorado, Denver
2024–2027
Evaluate the Safety, Tolerability, Pharmacokinetic Profile, Efficacy of Bl-M11D1
Site PI · Recruiting · Phase 1
SystImmune Inc.
2024–2027
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
Site PI · Recruiting · Phase 1, Phase 2
Syndax Pharmaceuticals
2019–2027
Research On Nicotinamide Riboside Supplement Support in MDS (ROSS Trial)
Sub-investigator · Recruiting · Phase 2
University of Colorado, Denver
2026–2030